A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.
The bill’s titles are written by its sponsor.
Mar 26, 2009
111th Congress, 2009–2010
Died in a previous Congress
This bill was introduced on March 26, 2009, in a previous session of Congress, but was not enacted.
Senator from New York
Read Text »
Last Updated: Mar 26, 2009
Length: 52 pages
Mar 26, 2009
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
S. 726 (111th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 111th Congress, which met from Jan 6, 2009 to Dec 22, 2010. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2017). S. 726 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act. Retrieved from https://www.govtrack.us/congress/bills/111/s726
“S. 726 — 111th Congress: Promoting Innovation and Access to Life-Saving Medicine Act.” www.GovTrack.us. 2009. October 18, 2017 <https://www.govtrack.us/congress/bills/111/s726>
|title=S. 726 (111th)
|accessdate=October 18, 2017
|author=111th Congress (2009)
|date=March 26, 2009
|quote=Promoting Innovation and Access to Life-Saving Medicine Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.